Latest Content

Current Treatments and New Combinations in EGFR-Mutant Lung Cancer

October 7th 2025, 8:00pm

By Dr. Nicolas Girard

Video

Dr. Nicolas Girard discussed the current treatment options for patients with EGFR-mutant lung cancer, including emerging combination regimens.

After Passing, Sister and Friend Finish Dr. Barbara Tatham’s Book

October 7th 2025, 7:00pm

By Spencer Feldman

Article

After Barbara Tatham’s passing from metastatic sarcoma, her sister and friend completed her memoir, highlighting caregiving, resilience and family support.

‘Love, Danielle’ Speaks to the Hereditary Cancer Community

October 7th 2025, 5:00pm

By Georgia Hurst

Article

As a Lynch syndrome previvor, I felt that the film “Love, Danielle” struck a deeply personal chord.

Top Lung Cancer News and Research Highlights from September 2025

October 7th 2025, 4:03pm

By Ryan Scott

Article

As we approach Lung Cancer Awareness Month this November, it’s important to reflect on the latest developments and insights in lung cancer research.

FDA Grants Orphan Drug Status to Cintredekin Besudotox for Glioblastoma

October 7th 2025, 3:00pm

By Spencer Feldman

Article

The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this aggressive brain cancer.

Why ‘One Size Does Not Fit All’ in Lung Cancer Treatment

October 7th 2025, 1:00pm

By Dr. Fred Hirsch

Video

Dr. Fred Hirsch highlighted how knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding of the disease.

Datroway Improves Progression, Survival in Triple-Negative Breast Cancer

October 6th 2025, 8:57pm

By Alex Biese

Article

In locally recurrent inoperable or metastatic TNBC, Datroway resulted in improvement in overall survival and progression-free survival.

Tagrisso Combination Improves Survival in EGFR-Mutant NSCLC

October 6th 2025, 8:00pm

By Dr. Pasi A. Janne

Video

In EGFR-mutated non-small cell lung cancer Tagrisso with pemetrexed and chemotherapy was associated with an improvement in survival.

What to Know: Your Questions Answered After a Breast Cancer Diagnosis

October 6th 2025, 7:00pm

By Ryan Scott

Article

October is Breast Cancer Awareness Month, and CURE is here to address some of the most common questions patients have after a breast cancer diagnosis.

Besides Oncologists, How Many ‘Gists’ Are There Anyway?

October 6th 2025, 5:00pm

By William Ramshaw

Article

My cancer journey began with a surgical oncologist who extracted my one-inch pancreatic tumor, taking with it the top third of my pancreas.

Mary’s Place by the Sea Offers Free Retreat and Respite for Women With Cancer

October 6th 2025, 4:00pm

By Alex Biese

Article

The New Jersey retreat is free for women during and two years after cancer treatment.

Pivekimab Sunirine Application Submitted to FDA for Rare Blood Cancer

October 6th 2025, 3:00pm

By Spencer Feldman

Article

A biologics license application for PVEK has been submitted to the FDA for blastic plasmacytoid dendritic cell neoplasm, a rare blood cancer.

What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?

October 6th 2025, 1:00pm

By Dr. Tanja A. Gruber

Video

CAR-T cell therapy has cured some children with blood cancers and is being studied in solid tumors, where responses differ due to how these cancers grow.

Top Breast Cancer Stories to Know as Breast Cancer Awareness Month Kicks Off

October 5th 2025, 6:00pm

By Ryan Scott

Article

As we kick off Breast Cancer Awareness Month, it’s an opportune time to reflect on some of the most important breast cancer stories shared last month.

Top GI News From September: GIST, Pancreatic and Colorectal Cancers

October 5th 2025, 2:00pm

By Spencer Feldman

Article

September’s top gastrointestinal cancer news covered long-term Gleevec results for GIST, a pancreatic cancer vaccine and FDA designations.